Tamoxifen in early breast cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference5 articles.
1. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998
2. Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues;Silva;Cancer Res,1997
3. Tamoxifen-induced fatty liver in breast cancer patients;Ogawa;Lancet,1998
4. Tamoxifen-associated steatohepatitis—report of three cases;Pinto;J Hepatol,1995
5. Alcohol-like liver disease in nonalcoholics;Diehl;Gastroenterology,1988
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies;Oncotarget;2016-11-21
2. Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy;PLOS ONE;2015-03-27
3. The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model;PLoS ONE;2013-06-03
4. CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues;Cancer Discovery;2012-07-09
5. Magnitude of Peroxisome Proliferator-Activated Receptor-γ Activation is Associated With Important and Seemingly Opposite Biological Responses in Breast Cancer Cells;Journal of Investigative Medicine;2001-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3